. . . . . "Brandejsk\u00FD, P." . . . "RIV/67985807:_____/11:00376168" . . . . . . "An Effect of Facilitation Physiotherapy on Immune Parameters of Patients with Multiple Sclerosis"@en . "238827" . . . . "Vliv facilita\u010Dn\u00ED fyzioterapie na imunologick\u00FD profil nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED"@cs . "Martinkov\u00E1, Patr\u00EDcia" . "An Effect of Facilitation Physiotherapy on Immune Parameters of Patients with Multiple Sclerosis"@en . "Hradec Kr\u00E1lov\u00E9" . "Vliv facilita\u010Dn\u00ED fyzioterapie na imunologick\u00FD profil nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED" . "Hradec Kr\u00E1lov\u00E9" . . . "Introduction: New neurophysiologic knowledge brings new possibilities of physiotherapy \u2013 a potential influence of the immune system in sense of immunomodulation. In this study, the impact of facilitation physiotherapy (FP) on the humoral and cellular immunity in patients with multiple sclerosis (MS) was monitored. Methods: Plasma immunoglobulins and membrane markers were measured in 20 stable MS patients twice during two months. During this time, 12 patients underwent 2 months FP and 8 did not change their habits. Plasma immunoglobulins were measured by laser nephelometry and membrane markers were stained by monoclonal antibody conjugated with fluorochromes and analyzed by flow cytometry. Wilcoxon signed-rank (paired) test and Wilcoxon rank-sum (two-sample) test was used for analyses. Results: We found significant changes in patients after FP in number of immunological parameters (IgG, IgG1, IgA, CD3+CD8+, CD3+, NK cells, lymphocytes, neutrophiles. while in patients who did not change their habits, there was a significant increase only in IgA. However, the amount of changes after two months follow-up was significantly different in the two groups only in IgA (p = 0.008). Conclusion: FP in MS influences the immunologic profile of patients with MS."@en . "Ku\u010Dera, P." . "GAUDEAMUS" . . "[E0F1494DF8EC]" . . . "978-80-7435-152-5" . "Z(AV0Z10300504)" . "Vliv facilita\u010Dn\u00ED fyzioterapie na imunologick\u00FD profil nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED"@cs . . "Podle nejnov\u011Bj\u0161\u00EDch v\u011Bdeck\u00FDch poznatk\u016F m\u016F\u017Eeme pomoci fyzioterapie ovliv\u0148ovat imunologick\u00E9 procesy a t\u00EDm zasahovat do patogeneze onemocn\u011Bni RS. Mo\u017Enost ovliv\u0148ovan\u00ED hypotalamo-hypofyz\u00E1rn\u00ED-adren\u00E1ln\u00ED osy je nejl\u00E9pe prozkoum\u00E1na a i u RS bylo ji\u017E provedeno n\u011Bkolik pilotn\u00EDch studii, kter\u00E9 potvrzuji, \u017Ee pravideln\u00E1 z\u00E1t\u011B\u017E submaxim\u00E1ln\u00ED intenzity vede k adapta\u010Dn\u00EDm (imunomodula\u010Dn\u00EDm) proces\u016Fm imunitn\u00EDho syst\u00E9mu (1, 2, 3). Fyzioterapie vyu\u017E\u00EDvaj\u00EDc\u00ED neurofyziologick\u00FDch poznatk\u016F m\u00E1 v\u0161ak mnohem v\u011Bt\u0161\u00ED potenci\u00E1l, kter\u00FD se v\u0161ak musi ov\u011B\u0159it. Potenci\u00E1ln\u00ED mechanizmy \u00FA\u010Dinku fyzioterapie na imunitn\u00ED syst\u00E9m vypl\u00FDvaj\u00ED z propojeni moze\u010Dku s limbick\u00FDm syst\u00E9mem (via motor cortex, hypotalamus a via hypotalamus - paleocerebellum a neocerebellum) (4). Fyzioterapie vyu\u017E\u00EDv\u00E1 r\u016Fzn\u00FDch senzomotorick\u00FDch technik v r\u016Fzn\u00FDch postur\u00E1ln\u00EDch pozic\u00EDch, \u010D\u00EDm\u017E stimuluje moze\u010Dek a t\u00EDm ovliv\u0148uje i dal\u0161\u00ED syst\u00E9my, mezi nimi i imunitn\u00ED. C\u00EDlem t\u00E9to studie je porovnat vliv facilitac\u00ED fyzioterapie na imunologick\u00FD profil nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED (RS)."@cs . . "multiple sclerosis; physiotherapy; facilitation; humoral and cellular immunity; immunomodulation; IgG; IgA; CD3+CD8+; CD19+"@en . "Optim\u00E1ln\u00ED p\u016Fsoben\u00ED t\u011Blesn\u00E9 z\u00E1t\u011B\u017Ee" . "Podle nejnov\u011Bj\u0161\u00EDch v\u011Bdeck\u00FDch poznatk\u016F m\u016F\u017Eeme pomoci fyzioterapie ovliv\u0148ovat imunologick\u00E9 procesy a t\u00EDm zasahovat do patogeneze onemocn\u011Bni RS. Mo\u017Enost ovliv\u0148ovan\u00ED hypotalamo-hypofyz\u00E1rn\u00ED-adren\u00E1ln\u00ED osy je nejl\u00E9pe prozkoum\u00E1na a i u RS bylo ji\u017E provedeno n\u011Bkolik pilotn\u00EDch studii, kter\u00E9 potvrzuji, \u017Ee pravideln\u00E1 z\u00E1t\u011B\u017E submaxim\u00E1ln\u00ED intenzity vede k adapta\u010Dn\u00EDm (imunomodula\u010Dn\u00EDm) proces\u016Fm imunitn\u00EDho syst\u00E9mu (1, 2, 3). Fyzioterapie vyu\u017E\u00EDvaj\u00EDc\u00ED neurofyziologick\u00FDch poznatk\u016F m\u00E1 v\u0161ak mnohem v\u011Bt\u0161\u00ED potenci\u00E1l, kter\u00FD se v\u0161ak musi ov\u011B\u0159it. Potenci\u00E1ln\u00ED mechanizmy \u00FA\u010Dinku fyzioterapie na imunitn\u00ED syst\u00E9m vypl\u00FDvaj\u00ED z propojeni moze\u010Dku s limbick\u00FDm syst\u00E9mem (via motor cortex, hypotalamus a via hypotalamus - paleocerebellum a neocerebellum) (4). Fyzioterapie vyu\u017E\u00EDv\u00E1 r\u016Fzn\u00FDch senzomotorick\u00FDch technik v r\u016Fzn\u00FDch postur\u00E1ln\u00EDch pozic\u00EDch, \u010D\u00EDm\u017E stimuluje moze\u010Dek a t\u00EDm ovliv\u0148uje i dal\u0161\u00ED syst\u00E9my, mezi nimi i imunitn\u00ED. C\u00EDlem t\u00E9to studie je porovnat vliv facilitac\u00ED fyzioterapie na imunologick\u00FD profil nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED (RS)." . "\u0158asov\u00E1, K." . "Vliv facilita\u010Dn\u00ED fyzioterapie na imunologick\u00FD profil nemocn\u00FDch s roztrou\u0161enou skler\u00F3zou mozkom\u00ED\u0161n\u00ED" . "1"^^ . "6"^^ . "4"^^ . "RIV/67985807:_____/11:00376168!RIV13-AV0-67985807" . . "2011-09-19+02:00"^^ .